Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients | Nature Communications
Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer | Oncogene
Life | Free Full-Text | Integrated Decision-Making in the Treatment of Colon-Rectal Cancer: The Case of KRAS-Mutated Tumors
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect
Colorectal Cancer
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Biomarkers in colorectal cancer: Current clinical utility and future perspectives
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
,0.jpg "Progress towards individualized treatment of colorectal cancer UAB Barcelona")
Progress towards individualized treatment of colorectal cancer UAB Barcelona
The Trouble With KRAS - Cancer Commons
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
Impact of RAS/RAF mutations on clinical and prognostic outcomes in metastatic colorectal cancer
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer - ScienceDirect
Cancers | Free Full-Text | KRAS G12C Mutations in NSCLC: From Target to Resistance
:max_bytes(150000):strip_icc()/kras-g12c-mutation-in-nsclc-4843957-v3-456bf340786c481b857d044b6a8cb307-b4828f2507074811b94472745e488299.png "KRAS Positive Lung Cancer: Testing and Management")
KRAS Positive Lung Cancer: Testing and Management
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Targeting the untargetable KRAS in cancer therapy - ScienceDirect
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
